Apria, Inc.

Apria, Inc. (APR) priced its initial public offering on Feb 12, 2021 at $20.00 per share, within its $19.00–$21.00 range, raising $150M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $704.2M. Citigroup was lead-left underwriter, joined by Goldman Sachs, BofA Securities and J.P. Morgan and others. Simpson Thacher advised the company and Davis Polk advised the underwriters.

Apria, Inc. operates in the durable medical equipment segment of the U.S. home healthcare market. Its home respiratory and obstructive sleep apnea treatment product lines are two of its core lines and together account for over 80% of 2019 net revenue.

Status

IPO

Ticker

APR

Exchange

Nasdaq Global Select

Priced

Feb 12, 2021

IPO price

$20.00

Price range

$19.00–$21.00

Raised

$150M

Market cap at IPO price

$704.2M

First filed

Jan 15, 2021

Underwriters

Citigroup, Goldman Sachs, BofA Securities, J.P. Morgan, UBS, Piper Sandler, Fifth Third, TD, Academy Securities, Blaylock Van and Penserra

Company counsel

Simpson Thacher

Underwriters' counsel

Davis Polk

Sector

Healthcare

Country / state

IN

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.